Getting Wyeth is the right think for PFE. They only paid marginally higher price for Wyeth in this troubling financial times. In my opinion, the timing is right. PFE need to look beyond 2010/11 on long term growth.
After few years , analysts are going to say, this was the best decision made.
The time is right now to buy PFE at levels below 20, if you truly believe disease, taxes and illness are here to say for ever and good pharma companies would be needed for years to come.